Close this search box.

Milind Shah, former MD of Medtronic India, joins Unitus Ventures as Healthcare Venture Partner

Shah to accelerate healthcare innovation in India by helping invest 100 crore in 8-10 startups by 2021.

29th May 2017, Bengaluru. Unitus Ventures, India’s leading impact venture fund investing in early-stage startups innovating for the masses, today announced the joining of Milind Shah as a Healthcare Venture Partner.

Capria - Milind ShahMilind Shah is a Proven Healthcare Operational Executive in the Indian Sub-Continent

Milind brings to Unitus Ventures over three decades of leadership experience in sales, marketing, and corporate planning positions across varied businesses, including healthcare and speciality chemicals with global industry majors like Medtronic, Henkel, 3M and Shell.  As Managing Director & VP Indian Sub-continent with Medtronic plc, a global leader in the medical technology industry, Milind led the operational and strategic plans for this region for 11 years. Milind was also a member of Medtronic’s global executive committee and a recipient of the prestigious Wallin award that recognises Medtronic leaders for business growth and talent development. Under Milind’s leadership, Medtronic India achieved and sustained market leadership across several businesses and delivered strong double digit revenue growth.

Milind brings a deep understanding of the healthcare eco-system, a strong network of relationships amongst upper echelons of medical technology companies and hospital chains, as well as hands on experience in developing & executing strategic plans, business model innovations and M&A.

Accelerating Healthcare for a Billion Plus Indians

Milind joins Unitus Ventures with a mandate of furthering healthcare innovation for India’s billion plus population by investing in 8-10 innovative and scalable healthcare businesses. In line with this aim, Unitus Ventures has earmarked INR 100 crore to invest in healthcare and also has launched the AmpHealth program, providing non-dilutive catalytic capital of up to INR 1.75 crore (USD $250, 000) to fund immediate pre-commercialisation coupled with up to INR 3.5 crore (USD $500, 000) of seed capital. Unitus is also currently running the fourth edition of its annual StartHealth competition, offering cash prize and access to expertise to the best  AI, analytics, devices and home health early-stage startups.

Further, Milind will also work closely with Unitus’ investees to prepare them for growth and follow-on funding by providing access to global healthcare practitioners, teaching and operating medical facilities.

“Chronic diseases are responsible for over 50 per cent of deaths in India. Yet, public expenditure on health remains one of the lowest, globally. Startups are making significant inroads by reducing financial barriers and accelerating innovation to make healthcare more accessible and affordable”, said Milind Shah, Healthcare Venture Partner, Unitus Ventures.

“Unitus Ventures’s strong healthcare focus, mentorship and global industry connections will deeply benefit startups, helping them launch their products, raise additional funding and scale faster. I am excited to partner with Unitus Ventures and utilize my experience to advance healthcare, particularly to India’s low-income masses.”

Impact of Unitus Ventures’s Healthcare Portfolio

Unitus Ventures’s portfolio company and early grantee of the AmpHealth program, UE LifeSciences is bringing low-cost breast cancer to India’s masses with iBreastExam — an FDA-approved, low-cost, easy-to-use, handheld breast cancer scanning device. Since Unitus’ initial funding, UE LifeSciences has raised a Series A investment round of USD $4 million from Aarin Capital, Kiran Mazumdar Shaw (Founder and CEO of Biocon) and Unitus Ventures.

“Providing new means of affordable healthcare access is no small task. Our commitment to healthcare is visible not just through our seed funding, but in how we work with these teams holistically. In addition to catalytic and seed funding, we have also built a highly-focused network of industry leaders and global healthcare companies to accelerate their growth. We’re extremely pleased to have Milind Shah help lead our efforts to sustainably improve healthcare in India.”, said Dave Richards, Co-founder and Managing Partner at Unitus Ventures.

Unitus Ventures has invested in multiple healthcare companies, including UE LifeSciences, AddressHealth, a comprehensive paediatric care network, and Welcare Health Systems, a low-cost tele-ophthalmology service. In 2016 alone, Unitus Ventures’s healthcare portfolio has impacted over 200,000 low-income lives, recorded 49 per cent Y-o-Y revenue growth and raised 2.2x additional capital.

Featured in:

unnamed       Capria - vccircle logo     Capria - full Disrupt logo      Capria - iw2 298x124 e1496135596600

About Unitus Ventures

Unitus Ventures is the leading impact venture fund investing in businesses innovating for the masses in India. Unitus invests in sectors including healthcare, education and financial technology. Unitus Ventures is backed by leading individual, family office, and foundation investors in the USA and India. Unitus Ventures is part of the Unitus Group, a premier financial services group operating in India and other emerging markets since 2000. Unitus Ventures is based in Bangalore and is a member of the Capria Network.

More about Unitus Ventures >


Subscribe to get latest updates

Be the first to hear the latest investment updates, AI tech trends, and partner insights from Capria Ventures by subscribing to our monthly newsletter. 

Report a Grievance

Capria Ventures and its related entities are committed to the highest standards of ethics and strictly enforce a zero-tolerance anti-corruption policy. Please report any suspicious activity to [email protected]. All reports will be treated with utmost urgency and resolved appropriately.

Unitus Ventures is now Capria India

Unitus Ventures, a leading venture capital firm in India, is joining forces with its US affiliate Capria Ventures, a Global South specialist, to operate with a unified global strategy under a single brand, Capria Ventures.